FDA expands Fractyl endoscopy trial to include untreated diabetes patients [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
clinical study for its endoscopic device to include patients with type 2 diabetes. The REVITALIZE-1 (NCT04419779) trial is set to examine the company's device which is designed to address the symptoms of obesity and type 2 diabetes by relining a patient's duodenum. Previously the trial was set only to examine the device's effect on patients taking insulin and up to three non-insulin drugs, including GLP-1-based therapies, but now the FDA has given the go-ahead for the trial to involve patients with inadequately controlled diabetes. Harith Rajagopalan, co-founder and CEO of Fractyl, said: “We are excited about the expansion of the protocol for REVITALIZE-1 because we believe Revita holds unique potential for tackling disease progression and prevention in the huge public health crisis that is T2D. “For patients currently managing T2D with medications or insulin, Revita aims to enhance glucose regulation and halt or slow down the disease's advancement, representing a paradigm shift
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Tandem Diabetes, DexCom see weakness following ADA conference [Seeking Alpha]Seeking Alpha
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions [Yahoo! Finance]Yahoo! Finance
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific SessionsBusiness Wire
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating OfficerBusiness Wire
TNDM
Earnings
- 5/2/24 - Beat
TNDM
Sec Filings
- 6/26/24 - Form 3
- 6/21/24 - Form 8-K
- 6/20/24 - Form 4
- TNDM's page on the SEC website